Zilia Secures Bridge Funding to Advance Medical Technology Innovations
Zilia, a cutting-edge medical technology company based in Quebec City, Canada, has recently secured undisclosed bridge funding to support its innovative projects.
The investment, which includes support from Linearis Ventures, will enable Zilia to expand the commercialization of its flagship technology, the Zilia Ocular.
Under the leadership of CEO Patrick Sauvageau, Zilia specializes in developing a platform that allows for the non-invasive measurement of biomarkers in the eye, with a primary focus on ocular oximetry. Through the integration of photonics and artificial intelligence, the company’s technology harnesses the optical properties of the eye and its direct connections to the vascular system and brain, providing valuable insights into ocular and overall health.
Stay tuned for more updates from Zilia as they continue to revolutionize the medical technology industry.
Published on: 07/05/2025
